Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Considers Expanding Third-Party List Without Related Guidances

This article was originally published in The Gray Sheet

Executive Summary

FDA's next expansion of its list of devices eligible for third-party review may include Class II devices for which there are no device-specific guidances yet available, according to agency officials.

You may also be interested in...



Industry Task Force, FDA Set Timeline For Jumpstarting Third-Party Program

A pan-industry/FDA task force will convene in the third week of April to discuss possible improvements to the agency's third party review program.

Industry Task Force, FDA Set Timeline For Jumpstarting Third-Party Program

A pan-industry/FDA task force will convene in the third week of April to discuss possible improvements to the agency's third party review program.

User Fees In Administration's Budget Request Aimed At Third-Party Program

FDA's Center for Devices and Radiological Health is hoping that the most recent user fee proposal set forth in the administration's FY 2001 budget request might breathe some life into the agency's moribund 510(k) third-party review program.

UsernamePublicRestriction

Register

OM004634

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel